BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is offering a funding opportunity through the BRAIN Initiative for preclinical proof of concept technologies aimed at advancing novel recording and modulation technologies for the human central nervous system (CNS). This initiative seeks to support the development of innovative technologies that can diagnose and treat CNS disorders, encouraging applications from diverse, interdisciplinary teams that include a Plan for Enhancing Diverse Perspectives (PEDP). With a total funding commitment of approximately $8 million, the NIH anticipates awarding 5-7 grants, each with a budget not exceeding $750,000 per year for a maximum of three years. Interested applicants should note that submission deadlines begin in April 2024, and for further inquiries, they can contact NIH Grants Information at grantsinfo@nih.gov.
Eligible Applicants
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.